Despite Expected Jan. Publication Date, White House Review of New 340B ADR Proposed Rule Is Approaching 100-Day Mark

HRSA's proposed replacement for its year-old 340B administrative dispute resolution process has been under White House review for almost 100 days.

The U.S. Health Resources and Services Administration’s (HRSA) proposed replacement for its year-old 340B administrative dispute resolution (ADR) process has been under White House review for almost 100 days—nearly a month longer that the anticipated release date announced in November.

Read More »

Hospitals Say the Three Confirmed to Have Left 340B Due to Fallout from COVID Are the Tip of the Iceberg

ProMedica Memorial Hospital in Ohio had to leave the 340B program last year when it lost eligibility due to fallout from COVID-19.

The U.S. Health Resources and Services Administration’s (HRSA) recent statement that only three hospitals so far have said on a federal form that they lost their 340B eligibility due to fallout from COVID-19 does not reflect the problem’s much bigger

Read More »

Rural Providers Ask Becerra for Action on 340B Contract Pharmacy and on Hospitals at Risk of Losing 340B Eligibility

The NRHA wants HHS to act against drug companies that deny 340B pricing when covered entities use contract pharmacies and ensure that rural hospitals do not lose their 340B eligibility due to factors related to COVID-19.

The National Rural Health Association (NRHA) asked U.S. Health and Human Services (HHS) Secretary Xavier Becerra this week to act against drug manufacturers that deny 340B pricing when covered entities use contract pharmacies.

NRHA CEO Alan Morgan also urged Becerra

Read More »

Merck Offering Refunds for 340B Overcharges

Merck is providing refunds to 340B covered entities for purchases of 17 products during the third quarter of 2020.

Drug manufacturer Merck is providing 340B covered entities with refunds for overcharges on 17 NDCs for purchases between Jan. 1 and March 31, 2019, the company says in a new public notice on the U.S. Health Resources and Services

Read More »

HHS Secretary Becerra Pledges to Keep Fighting Against 340B Contract Pharmacy Restrictions “Because it’s the Law”

HHS Secretary Xavier Becerra told health centers yesterday that “we’re going to continue to fight” drug manufacturers that restrict 340B pricing when covered entities use contract pharmacies “because it’s the law.”

U.S. Health and Human Services (HHS) Secretary Xavier Becerra said yesterday that “we’re going to continue to fight” drug manufacturers that restrict 340B pricing when covered entities use contract pharmacies “because it’s the law.”

Becerra’s Feb. 14 remarks about manufacturers’

Read More »

In a Win for Health Centers, 340B ADR Panel Says Proceedings Against AstraZeneca & Sanofi Must Go On

A 340B administrative dispute resolution (ADR) panel said it will not stop proceedings in the National Association of Community Health Centers’ complaint against AstraZeneca and Sanofi.

A 340B administrative dispute resolution (ADR) panel decided late last week that it will not stop proceedings in the National Association of Community Health Centers’ (NACHC) dispute-resolution petition over drug manufacturers AstraZeneca and Sanofi’s conditions on 340B pricing when covered

Read More »

In a Move that May Get Significant Pushback, Lilly Signals that it Can Recoup 340B Underpayments from Entities at its Discretion

Eli Lilly signaled late last week that it thinks it can seek more for its products from 340B covered entities if it learns later that it charged them less than what the company perceives the law allows.

Drug manufacturer Lilly indicated late last week that it reserves the right to seek additional compensation for its products from 340B covered entities if it learns later that it charged them less than what the company perceives the 340B statute

Read More »

News Alert: Biden Praises Congresswoman’s “Relentless” Work on 340B During Major Speech on Drug Pricing Reform

During a major speech today on drug pricing reform, President Biden applauded U.S. Rep. Abigail Spanberger (D-Va.) for her “relentless” work to ensure that the 340B statute “is actually enforced.”

President Joe Biden today during a major speech on drug pricing reform applauded U.S. Rep. Abigail Spanberger (D-Va.) for being “relentless in making sure” that the 340B statute “is actually enforced.”

Biden and U.S. Health and Human Services (HHS) Secretary

Read More »

Biden and Becerra Slated to Speak at NACHC Event Next Week

President Joe Biden (left) and HHS Secretary Xavier Becerra are scheduled to speak on Monday, Feb. 14, during the National Association of Community Health Centers’ (NACHC) Policy and Issues Virtual Forum.

President Joe Biden and U.S. Health and Human Services (HHS) Secretary Xavier Becerra are scheduled to speak on Monday, Feb. 14, during the National Association of Community Health Centers’ Policy and Issues Virtual Forum, NACHC announced on Tuesday.

Securing Biden

Read More »

HRSA Says at Least Three Hospitals Have Lost 340B Eligibility So Far Due to COVID-19 Patient Mix Changes

St. Elizabeth Healthcare in Ft. Thomas, Ky., is one of three hospitals known to have withdrawn from the 340B program because changes in patient mix linked to the COVID-19 pandemic caused them to lose their eligibility. More are expected to lose eligibility soon.

The U.S. Health Resources and Services Administration (HRSA) said yesterday it knows of three hospitals that have withdrawn from the 340B program because changes in patient mix linked to the COVID-19 pandemic caused them to lose their eligibility. There could

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live